NASTAD Releases Key Findings of the 2014 National AIDS Drug Assistance Program (ADAP) Monitoring Project Annual Report

By Amanda Bowes, Associate, Health Care Access and Viral Hepatitis, NASTAD

2014 National ADAP Monitoring Project Annual ReportToday, the National Alliance of State and Territorial AIDS Directors (NASTAD) released key findings of the 2014 National ADAP Monitoring Project Annual Report. The National ADAP Monitoring Project is NASTAD’s long-standing effort to document new developments and challenges facing AIDS Drug Assistance Programs (ADAPs), assessing key trends over time and providing the latest available data on the status of ADAPs. For the last 19 years, NASTAD has provided comprehensive analysis about ADAPs through The Report.

The Report provides an overview of the status of ADAPs as they prepared for full implementation of the Affordable Care Act (ACA). Continue reading

Advocates Continue Push to Require Insurers to Accept Ryan White Payments

By Amy Killelea, Associate Director, Health Care Access, NASTAD

CMS ACA Ryan White Payment Guidance

Insurers in two states – Blue Cross and Blue Shield in Louisiana and North Dakota – have prohibited the acceptance of premium payments from the Ryan White Program/AIDS Drug Assistance Program (ADAP) on behalf of eligible low-income clients. These policies risk leaving hundreds of low-income people living with HIV unable to access Qualified Health Plan coverage through the Affordable Care Act (ACA) and have prompted a swift federal and state advocacy response.

Continue reading

Update: Ryan White Program Current Status

By Ann Lefert, National Alliance of State and Territorial AIDS Directors and Bill McColl, AIDS United, Co-Chairs of the Ryan White Work Group, Federal AIDS Policy Partnership

Federal AIDS Policy Partnership (FAPP)As Co-Chairs of the Ryan White Work Group, we wanted to provide you with an update on the Ryan White Program. As you know, the current authorization ends on September 30, 2013.  However, there is no “sunset” provision in the legislation.  Therefore even if Congress does not take action, the Ryan White Program will remain a part of the law allowing funding to continue to be appropriated through the annual congressional appropriations process. Continue reading

Action Alert: Urge Congress to Fully Fund Domestic HIV/AIDS and Viral Hepatitis Programs

By Emily McCloskey, Manager, Policy and Legislative Affairs, NASTAD

Action: Contact your Senators to ask them to fully fund domestic HIV/AIDS and viral hepatitis programs

NHTD 2013 Call In DayThe Senate Appropriations Committee is expected to vote on the bill that funds domestic HIV/AIDS and viral hepatitis programs the week of July 7. The National Alliance of State and Territorial AIDS Directors (NASTAD) and the larger HIV community are leading a call in day on June 27 to ask the Senate to help prevent further cuts and to fully fund domestic HIV/AIDS and viral hepatitis prevention, care, treatment, and research programs. Calls on this issue to individual offices can make a difference. Please send the action alert to your networks and communities. If possible, NASTAD also asks you to reach out to your Senators on June 27, National HIV Testing Day (NTHD), and let them know the importance of HIV and viral hepatitis programs. Continue reading

NASTAD Releases Module Two of the 2013 National AIDS Drug Assistance Program (ADAP) Monitoring Project Report

FOR IMMEDIATE RELEASE: April 2, 2013
Contact:
Meico Whitlock, 202-434-8094, www.NASTAD.org

ADAP Enrolling and Serving More Clients than Ever Before; Future Funding Uncertain

Download the 2013 National AIDS Drug Assistance Program (ADAP) Monitoring Project Annual Report (Module 2) (PDF)

Please contact Meico Whitlock (202-434-8094) for an interview about the report.

2013 NASTAD NAMP ReportWashington, DC – Today, the National Alliance of State and Territorial AIDS Directors (NASTAD) released the second and final module of its 2013 National ADAP Monitoring Project Annual Report. The National ADAP Monitoring Project is NASTAD’s long-standing effort to document new developments and challenges facing AIDS Drug Assistance Programs (ADAPs), assessing key trends over time and providing the latest available data on the status of ADAPs. For the last 18 years, NASTAD has provided comprehensive analysis about ADAPs through The Report.

Continue reading